The Problem of Aducanumab for the Treatment of Alzheimer Disease

被引：36
|
作者：
Alexander, G. Caleb [1 ,2 ]
Karlawish, Jason [3 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Baltimore, MD USA
[3] Univ Penn, Philadelphia, PA 19104 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2021年 / 174卷 / 09期
关键词：
D O I：
10.7326/M21-2603
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1303 / +
页数：3
相关论文
共 50 条
  • [21] Aducanumab Anti-β-amyloid monoclonal antibody Treatment of Alzheimer's disease
    Khanna, G.
    Bhandari, R.
    Kuhad, A.
    Kuhada, A.
    DRUGS OF THE FUTURE, 2019, 44 (02) : 115 - 121
  • [22] Aducanumab for Alzheimer's disease: A regulatory perspective
    Nistico, Robert
    Borg, John Joseph
    PHARMACOLOGICAL RESEARCH, 2021, 171
  • [23] Alzheimer disease and aducanumab: adjusting our approach
    Dennis J. Selkoe
    Nature Reviews Neurology, 2019, 15 : 365 - 366
  • [24] Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease
    Salloway, Stephen
    Cummings, Jeffrey
    NEUROLOGY, 2021, 97 (11) : 543 - 544
  • [25] Aducanumab as a Novel Treatment for Alzheimer's Disease: A Decade of Hope, Controversies, and the Future
    Esang, Michael
    Gupta, Mayank
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [26] Oligomannate and aducanumab: Novel drugs for alzheimer disease
    Rissardo, Jamir Pitton
    Caprara, Ana Leticia Fornari
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2020, 12 (04): : 327 - 328
  • [27] Treatment interval dependent effects of aducanumab therapy on Alzheimer's disease neuropathology
    Patel, S.
    Lopresti, B.
    Lingler, J.
    Lopez, O.
    Kofler, J.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 489 - 490
  • [28] Profiling aducanumab as a treatment option for alzheimer's disease: an overview of efficacy, safety and tolerability
    Thussu, Shreeya
    Naidu, Aniketh
    Manivannan, Sindhu
    Grossberg, George T.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2024, 24 (11) : 1045 - 1053
  • [29] Alzheimer disease neuropathology in a patient previously treated with aducanumab
    Edward D. Plowey
    Thierry Bussiere
    Raj Rajagovindan
    Jennifer Sebalusky
    Stefan Hamann
    Christian von Hehn
    Carmen Castrillo-Viguera
    Alfred Sandrock
    Samantha Budd Haeberlein
    Christopher H. van Dyck
    Anita Huttner
    Acta Neuropathologica, 2022, 144 : 143 - 153
  • [30] The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
    Jeff Sevigny
    Ping Chiao
    Thierry Bussière
    Paul H. Weinreb
    Leslie Williams
    Marcel Maier
    Robert Dunstan
    Stephen Salloway
    Tianle Chen
    Yan Ling
    John O’Gorman
    Fang Qian
    Mahin Arastu
    Mingwei Li
    Sowmya Chollate
    Melanie S. Brennan
    Omar Quintero-Monzon
    Robert H. Scannevin
    H. Moore Arnold
    Thomas Engber
    Kenneth Rhodes
    James Ferrero
    Yaming Hang
    Alvydas Mikulskis
    Jan Grimm
    Christoph Hock
    Roger M. Nitsch
    Alfred Sandrock
    Nature, 2016, 537 : 50 - 56
12345